Search results for: Pharmaceutical

ROSEN, A WORLD-CLASS LAW FIRM, ENCOURAGES AMPIO PHARMACEUTICALS TO

WHY: New York, NY – (NewMediaWire) – October 8, 2022 – Rosen Law Firm, a global investor rights law firm, is reminding buyers of Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) securities between December 29, 2020 and August 3, 2022, both dates inclusive (the “class period”), meaning October 17, 2022 Deadline for Lead Plaintiff. SO WHAT: […]

Zynerba Pharmaceuticals Announces Grant of New US Patent for

DEVON, Pa., Oct. 6, 2022 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticalsinc CYNEthe leading provider of innovative pharmaceutically manufactured transdermal cannabinoid therapies for rare neuropsychiatric disorders, announced today that the U.S. Patent and Trademark Office has granted Patent No. 11,458,110, entitled “Treatment of Fragile X Syndrome with Cannabidiol,” which Contains claims relating to methods of treating fragile […]

CENTESSA PHARMACEUTICALS SHAREHOLDER WARNING BY FORMER LOUISIANA

NEW ORLEANS, Oct. 04, 2022 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Louisiana Attorney General Charles C. Foti, Jr., remind investors that they have until November 28, 2022 Lead plaintiff’s motions in a securities class action against Centessa Pharmaceuticals plc CNTAif they purchased or otherwise acquired the Company’s securities […]

CENTESSA PHARMACEUTICALS SHAREHOLDER WARNING BY FORMER

NEW ORLEANS, Oct. 04, 2022 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Louisiana Attorney General Charles C. Foti, Jr., are reminding investors that they still have time November 28, 2022 Lead Plaintiff motions to file in a securities class action lawsuit against Centessa Pharmaceuticals plc (NasdaqGS: CNTA) if they […]

Centessa Pharmaceuticals plc Shareholder Warning: Robbins LLP

SAN DIEGO, Oct. 4, 2022 (GLOBE NEWSWIRE) — The class: Law firm for shareholder rights Robbins LLP Reminds investors that a shareholder has filed a class action lawsuit on behalf of all persons and entities that acquired American Depository Shares (ADS) from Centessa Pharmaceuticals plc (NASDAQ: CNTA) pursuant to the Company’s initial public offering of […]

Centessa Pharmaceuticals plc shareholder warning: Robbins LLP recalled

SAN DIEGO, Oct. 4, 2022 (GLOBE NEWSWIRE) — The class: Law firm for shareholder rights Robbins LLP reminds investors that a shareholder has filed a class action lawsuit on behalf of all individuals and entities that have purchased Centessa Pharmaceuticals plc CNTA American Depository Shares (ADS) pursuant to the Company’s initial public offering on May […]

High Times, Elegance, Emerald Health Pharmaceuticals among 8 Cannabis

On September 30th, the Securities and Exchange Commission (SEC) announced that it had billed eight cannabis stocks, including a stock promotion program Emerald Health Pharmaceuticals, Elegance Brands Inc. (now Sway Energy Corp.), and High Times stocks HTHC, reported Debra Borchardt for Green Market Report. “The SEC says investors bought $80 million worth of securities following […]

SHAREHOLDER OF CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA).

Have you lost money investing in Centessa Pharmaceuticals? If yes, please visit us Class Action by Centessa Pharmaceuticals plc Shareholders or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights. NEW YORK, Oct. 04, 2022 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP, a nationally recognized investor rights law firm, is reminding investors of […]

AMPE Investor News: Trusted National Trial Counsel ROSEN encourages Ampio Pharmaceuticals to

NEW YORK, Oct. 4, 2022 (GLOBE NEWSWIRE) — Why:Rosen Law Firm, a global investor rights law firm, recalls purchases by Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) between December 29, 2020 and August 3, 2022, both dates including (the “Class Period”) buyers of securities ,October 17, 2022 is the lead plaintiff’s deadlineImportant day. What:If you purchased […]

SHAREHOLDER OF CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA).

Have you lost money investing in Centessa Pharmaceuticals? If yes, please visit us Class Action by Centessa Pharmaceuticals plc Shareholders or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights. NEW YORK, Sept. 29, 2022 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP announces that a securities class action has been filed on behalf […]

CNS Pharmaceuticals (NASDAQ: CNSP) is exhibiting at Innovations in

CNS Pharmaceuticals (NASDAQ:CNSP) is a biopharmaceutical company focused on developing novel treatments for primary and metastatic cancers of the brain and central nervous system. The company announced today that its Chief Executive Officer, John Climaco, will present below event at 1:00 p.m. ET on Wednesday, September 28, 2022: Virtual Investor Innovations in Oncology – Ongoing […]